IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre 15-05-2024, 11:38

Lantronix Announces New X300 Compact Cellular IoT Gateway Solution, Ideal for Mission-Critical Applications 28-03-2023, 18:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26